Avalo Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Avalo Therapeutics stock have an average target of 40.57, with a low estimate of 15 and a high estimate of 52. The average target predicts an increase of 215.47% from the current stock price of 12.86.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$40.57	$40	$52
Change	+16.64%	+215.47%	+211.04%	+304.35%

Analyst Ratings

The average analyst rating for Avalo Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	6	5	5	6	6	4
Buy	2	3	3	3	2	4
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	10	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Harrison BTIG	BTIG	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+211.04%	Apr 13, 2026
Andy Chen Wolfe Research	Wolfe Research	Buy Initiates $48	Buy	Initiates	$48	+273.25%	Apr 9, 2026
Jason Butler Citizens	Citizens	Buy Initiates $52	Buy	Initiates	$52	+304.35%	Apr 6, 2026
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $25 → $40	Strong Buy	Maintains	$25 → $40	+211.04%	Mar 25, 2026
Julian Harrison BTIG	BTIG	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+211.04%	Mar 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 59.00K

Revenue Next Year

n/a

EPS This Year

-3.51

from -5.84

EPS Next Year

-3.94

from -3.51

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.40M	18.05M	1.92M	441.00K	59.00K	-	-
Revenue Growth	-19.42%	234.40%	-89.34%	-77.08%	-86.62%	-	-
EPS	-2,331.41	-1,062.65	-113.58	-20.91	-5.84	-3.51	-3.94
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.94	-2.78
Avg	-3.51	-3.94
Low	-3.94	-4.80

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.